Richard C Briscoe Anaesthetics Limited - Period Ending 2018-03-31

Richard C Briscoe Anaesthetics Limited - Period Ending 2018-03-31


Richard C Briscoe Anaesthetics Limited 9507891 false 2017-04-01 2018-03-31 2018-03-31 The principal activity of the company is is the provision of anaesthetic services Digita Accounts Production Advanced 6.21.8540.0 Software true 9507891 2017-04-01 2018-03-31 9507891 2018-03-31 9507891 bus:Director1 1 2018-03-31 9507891 core:RetainedEarningsAccumulatedLosses 2018-03-31 9507891 core:ShareCapital 2018-03-31 9507891 core:CurrentFinancialInstruments 2018-03-31 9507891 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 9507891 core:FurnitureFittings 2018-03-31 9507891 core:OfficeEquipment 2018-03-31 9507891 bus:SmallEntities 2017-04-01 2018-03-31 9507891 bus:AuditExemptWithAccountantsReport 2017-04-01 2018-03-31 9507891 bus:FullAccounts 2017-04-01 2018-03-31 9507891 bus:SmallCompaniesRegimeForAccounts 2017-04-01 2018-03-31 9507891 bus:RegisteredOffice 2017-04-01 2018-03-31 9507891 bus:Director1 2017-04-01 2018-03-31 9507891 bus:Director1 1 2017-04-01 2018-03-31 9507891 bus:PrivateLimitedCompanyLtd 2017-04-01 2018-03-31 9507891 core:ComputerEquipment 2017-04-01 2018-03-31 9507891 core:FurnitureFittings 2017-04-01 2018-03-31 9507891 core:OfficeEquipment 2017-04-01 2018-03-31 9507891 countries:England 2017-04-01 2018-03-31 9507891 2017-03-31 9507891 core:FurnitureFittings 2017-03-31 9507891 core:OfficeEquipment 2017-03-31 9507891 2016-04-01 2017-03-31 9507891 2017-03-31 9507891 bus:Director1 1 2017-03-31 9507891 core:RetainedEarningsAccumulatedLosses 2017-03-31 9507891 core:ShareCapital 2017-03-31 9507891 core:CurrentFinancialInstruments 2017-03-31 9507891 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 9507891 core:FurnitureFittings 2017-03-31 9507891 core:OfficeEquipment 2017-03-31 9507891 bus:Director1 1 2016-04-01 2017-03-31 iso4217:GBP xbrli:pure

Registration number: 9507891

Richard C Briscoe Anaesthetics Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2018

(taking advantage of s444 of the Companies Act 2006)

Stables Thompson & Briscoe
Chartered Accountants & Business Advisers
Lowther House
Lowther Street
Kendal
Cumbria
LA9 4DX

 

Richard C Briscoe Anaesthetics Limited

(Registration number: 9507891)
Balance Sheet as at 31 March 2018

Note

2018
£

2017
£

Fixed assets

 

Tangible assets

4

840

1,811

Current assets

 

Debtors

5

7,258

10,293

Cash at bank and in hand

 

4,578

9,996

 

11,836

20,289

Creditors: Amounts falling due within one year

6

(8,029)

(8,487)

Net current assets

 

3,807

11,802

Net assets

 

4,647

13,613

Capital and reserves

 

Called up share capital

12

12

Profit and loss account

4,635

13,601

Total equity

 

4,647

13,613

For the financial year ending 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Directors' report and Profit and Loss Account has been taken.

Approved and authorised by the Board on 16 November 2018 and signed on its behalf by:
 

.........................................

Dr RC Briscoe
Director

 

Richard C Briscoe Anaesthetics Limited

Notes to the Financial Statements for the Year Ended 31 March 2018

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Lowther House
Lowther Street
Kendal
Cumbria
LA9 4DX

These financial statements were authorised for issue by the Board on 16 November 2018.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Richard C Briscoe Anaesthetics Limited

Notes to the Financial Statements for the Year Ended 31 March 2018

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33.33% straight line

Fixtures and fittings

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2017 - 1).

 

Richard C Briscoe Anaesthetics Limited

Notes to the Financial Statements for the Year Ended 31 March 2018

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 April 2017

2,095

1,658

3,753

At 31 March 2018

2,095

1,658

3,753

Depreciation

At 1 April 2017

838

1,104

1,942

Charge for the year

419

552

971

At 31 March 2018

1,257

1,656

2,913

Carrying amount

At 31 March 2018

838

2

840

At 31 March 2017

1,257

554

1,811

5

Debtors

2018
£

2017
£

Trade debtors

5,700

5,218

Other debtors

1,558

5,075

Total current trade and other debtors

7,258

10,293

6

Creditors

Creditors: amounts falling due within one year

2018
£

2017
£

Due within one year

 

Taxation and social security

 

7,296

7,857

Accruals and deferred income

 

733

630

 

8,029

8,487

 

Richard C Briscoe Anaesthetics Limited

Notes to the Financial Statements for the Year Ended 31 March 2018

7

Related party transactions

Transactions with directors

2018

At 1 April 2017
£

Advances to directors
£

Repayments by director
£

At 31 March 2018
£

Dr RC Briscoe

(2,510)

(3,056)

4,008

(1,558)

         
       

 

2017

At 1 April 2016
£

Advances to directors
£

Repayments by director
£

At 31 March 2017
£

Dr RC Briscoe

440

(3,933)

983

(2,510)